References
- Coenen EA, Zwaan CM, Reinhardt D, et al. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Blood. 2013;122:2704–2713.
- Camus V, Etancelin P, Jardin F, et al. Spontaneous remission in three cases of AML M5 with NPM1 mutation. Clin Case Rep. 2015;3:955–959.
- Muller CI, Trepel M, Kunzmann R, et al. Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature. Eur J Haematol. 2004;73:62–66.
- Haferlach T, Kohlmann A, Klein HU, et al. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia. 2009;23:934–943.
- Troke PJ, Kindle KB, Collins HM, et al. MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp. 2006;(73):23–39.
- Esteyries S, Perot C, Adelaide J, et al. NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. Leukemia. 2008;22:663–665.
- Kitabayashi I, Aikawa Y, Yokoyama A, et al. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia. 2001;15:89–94.
- Chaffanet M, Gressin L, Preudhomme C, et al. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosom Cancer. 2000;28:138–144.
- Iyer NG, Ozdag H, Caldas C. p300/CBP and cancer. Oncogene. 2004;23:4225–4231.
- Hudecova I. Digital PCR analysis of circulating nucleic acids. Clin Biochem. 2015;48:948–956.